Trial intelligence / Profile preview

Melatonin with Neoadjuvant Chemotherapy in Locally Advanced OSCC

NCT04137627Phase 3Completed

Sponsor
Universitas Indonesia
Start
Jul 2017
Primary completion
Jul 2018
Modality
Small Molecules
Countries
1
01

Overview

A Phase 3 trial of melatonin in oral squamous cell carcinoma (OSCC), sponsored by Universitas Indonesia. Started Jul 2017; status: completed.

02

Drugs

melatonin
03

Conditions

oral squamous cell carcinoma (OSCC)

Beyond the preview

Go deeper on NCT04137627.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT04137627.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call